"Interleukin-9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A multifunctional cytokine secreted by primarily by activated TH2 CELLS that may play a role as a regulator of allergic INFLAMMATION. It has been shown to enhance the growth and CELL DIFFERENTIATION of MAST CELLS, and can act on a variety of other immune cells.
Descriptor ID |
D016906
|
MeSH Number(s) |
D12.644.276.374.465.377 D12.776.467.374.465.312 D23.529.374.465.377
|
Concept/Terms |
Interleukin-9- Interleukin-9
- Interleukin 9
- T-Cell Growth Factor P40
- T Cell Growth Factor P40
- P40 T-Cell Growth Factor
- P40 T Cell Growth Factor
- IL-9
- IL9
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-9".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-9".
This graph shows the total number of publications written about "Interleukin-9" by people in this website by year, and whether "Interleukin-9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-9" by people in Profiles.
-
IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation. Mucosal Immunol. 2020 11; 13(6):919-930.
-
Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-? in Tg2576 Mice. Int J Mol Sci. 2020 Mar 03; 21(5).
-
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome. Clin Cancer Res. 2018 09 15; 24(18):4416-4428.
-
Gene Expression-Based Predictive Models of Graft Versus Host Disease-Associated Dry Eye. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4570-81.
-
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy. Cancer Immunol Immunother. 2014 Aug; 63(8):835-45.
-
Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. Proc Natl Acad Sci U S A. 2014 Feb 11; 111(6):2265-70.
-
Cutting edge: Smad2 and Smad4 regulate TGF-?-mediated Il9 gene expression via EZH2 displacement. J Immunol. 2013 Nov 15; 191(10):4908-12.
-
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial. J Thorac Oncol. 2013 May; 8(5):658-61.
-
Th9 cells promote antitumor immune responses in vivo. J Clin Invest. 2012 Nov; 122(11):4160-71.
-
Regulation of IL-9 expression by IL-25 signaling. Nat Immunol. 2010 Mar; 11(3):250-6.